Published in The BMJ · View the paper (DOI)
A major clinical trial led by the University of Nottingham found that LSVT LOUD was more effective at reducing the impact of voice problems in people with Parkinson's disease compared to no speech and language therapy or NHS delivered therapy. The treatment improved communication skills, enabling participants to go out and socialize wi...
Coverage from 2 institutions